$96.1 Million is the total value of UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO's 24 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 172.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TSHA | New | TAYSHA GENE THERAPIES INC | $44,800,000 | – | 2,000,000 | +100.0% | 46.63% | – |
| VT | Sell | VANGUARD TOTAL WORLD STOCK ETFetfs | $14,637,000 | +7.8% | 181,506 | -0.0% | 15.24% | -71.0% |
| CSTL | New | CASTLE BIOSCIENCES INC | $12,632,000 | – | 245,527 | +100.0% | 13.15% | – |
| IMTX | New | IMMATICS NV | $7,400,000 | – | 697,431 | +100.0% | 7.70% | – |
| TXN | TEXAS INSTRUMENTS INC | $4,569,000 | +12.5% | 32,000 | 0.0% | 4.76% | -69.7% | |
| TFFP | New | TFF PHARMACEUTICALS INC | $4,076,000 | – | 220,666 | +100.0% | 4.24% | – |
| SOLY | SOLITON INC | $3,247,000 | -1.8% | 425,000 | 0.0% | 3.38% | -73.6% | |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $1,983,000 | -23.3% | 279,678 | 0.0% | 2.06% | -79.4% | |
| CHRS | New | COHERUS BIOSCIENCES INC | $753,000 | – | 41,036 | +100.0% | 0.78% | – |
| PHR | New | PHREESIA INC | $493,000 | – | 15,351 | +100.0% | 0.51% | – |
| APEN | APOLLO ENDOSURGERY INC | $472,000 | +3.5% | 279,037 | 0.0% | 0.49% | -72.1% | |
| PLXP | PLX PHARMA INC | $202,000 | -0.5% | 62,673 | 0.0% | 0.21% | -73.2% | |
| IAU | New | ISHARES GOLD TRUSTinvestment funds, public markets-global equity | $115,000 | – | 6,400 | +100.0% | 0.12% | – |
| DIS | New | WALT DISNEY CO/THE | $99,000 | – | 800 | +100.0% | 0.10% | – |
| HD | New | HOME DEPOT INC/THE | $97,000 | – | 350 | +100.0% | 0.10% | – |
| ORCL | New | ORACLE CORPORATION | $90,000 | – | 1,503 | +100.0% | 0.09% | – |
| ACWI | New | ISHARES MSCI ACWI ETFinvestment funds, public markets-global equity | $88,000 | – | 1,106 | +100.0% | 0.09% | – |
| EW | New | EDWARDS LIFESCIENCES CORP | $67,000 | – | 837 | +100.0% | 0.07% | – |
| SRE | New | SEMPRA ENERGY | $64,000 | – | 537 | +100.0% | 0.07% | – |
| DHR | New | DANAHER CORP | $53,000 | – | 245 | +100.0% | 0.06% | – |
| LXRX | LEXICON PHARMACEUTICALS INC | $51,000 | -28.2% | 35,714 | 0.0% | 0.05% | -80.7% | |
| NKE | New | NIKE INC | $50,000 | – | 400 | +100.0% | 0.05% | – |
| BRO | New | BROWN & BROWN, INC | $34,000 | – | 753 | +100.0% | 0.04% | – |
| POR | PORTLAND GENERAL ELECTRIC CO | $4,000 | -20.0% | 118 | 0.0% | 0.00% | -78.9% | |
| SQ | Exit | SQUARE INC | $0 | – | -500 | -100.0% | -0.20% | – |
| SYK | Exit | STRYKER CORP | $0 | – | -3,800 | -100.0% | -2.65% | – |
| AMGN | Exit | AMGEN INC | $0 | – | -3,615 | -100.0% | -3.30% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-06
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEXAS INSTRUMENTS INC | 41 | Q3 2023 | 31.2% |
| PORTLAND GENERAL ELECTRIC CO | 38 | Q3 2023 | 0.0% |
| LEXICON PHARMACEUTICALS INC | 33 | Q3 2023 | 1.7% |
| AEGLEA BIOTHERAPEUTICS INC | 27 | Q2 2023 | 11.0% |
| APOLLO ENDOSURGERY INC | 24 | Q1 2023 | 5.6% |
| PLX PHARMA INC | 23 | Q1 2023 | 1.7% |
| VANGUARD MSCI EMERGING MKTS | 22 | Q2 2019 | 10.3% |
| VANGUARD ENERGY ETF | 22 | Q2 2019 | 8.7% |
| VANGUARD S&P 500 ETF | 21 | Q3 2023 | 11.8% |
| VANGUARD MSCI EAFE ETF | 20 | Q2 2019 | 13.1% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Taysha Gene Therapies, Inc. | September 24, 2021 | 1,156,255 | 3.0% |
| ZIOPHARM ONCOLOGY INC | February 12, 2016 | 9 | 0.0% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-03-05 |
| 13F-HR | 2024-02-28 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-04 |
| 3 | 2023-06-02 |
| 13F-HR | 2023-05-22 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-04 |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.